BioRestorative Therapies (BRTX) FCF Margin Growth (5y) (2017 - 2025)
BioRestorative Therapies (BRTX) FCF Margin Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.02 Mn | 17,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -928,596.00 |
| Sep 30, 2025 | -2.11 Mn |
| Jun 30, 2025 | 131,563.00 |
| Mar 31, 2025 | -953,518.00 |
| Dec 31, 2024 | 20,836.00 |
| Sep 30, 2024 | 376,555.00 |
| Jun 30, 2024 | 247,069.00 |
| Mar 31, 2024 | 12,236.00 |
| Dec 31, 2023 | -323,513.00 |
| Sep 30, 2023 | 132,304.00 |
| Jun 30, 2023 | 72,944.00 |
| Mar 31, 2023 | -159,993.00 |
| Dec 31, 2022 | -4.12 Mn |
| Sep 30, 2022 | -173,862.00 |
| Jun 30, 2022 | 187,652.00 |
| Mar 31, 2022 | 676,249.00 |
| Dec 31, 2021 | -531,246.00 |
| Sep 30, 2021 | 1.69 Mn |
| Jun 30, 2021 | 173,293.00 |
| Mar 31, 2021 | 1.53 Mn |